References
- Centers for Disease Control and Prevention [website on the Internet]National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011AtlantaUS Department of Health and Human Services, Centers for Disease Control and Prevention2011 Available from: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdfAccessed July 27, 2012
- GarberAJAbrahamsonMJBarzilayJIAACE comprehensive diabetes management algorithm 2013Endocr Pract201319232733623598536
- GarberAJDonovanDSDandonaPBruceSParkJSEfficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetesJ Clin Endocrinol Metab20038883598360412915642
- PerezAZhaoZJacksRSpanheimerREfficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DMCurr Med Res Opin200925122915292319827910
- CharbonnelBSchernthanerGBrunettiPLong-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetesDiabetologia20054861093110415889234
- CharbonnelBHMatthewsDRSchernthanerGHanefeldMBrunettiPQUARTET Study GroupA long-term comparison of pioglitazone and gliclazide in patients with type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trialDiabet Med200522439940515787663
- NauckMAMeiningerGShengDTerranellaLSteinPPSitagliptin Study 024 GroupEfficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trialDiabetes Obes Metab20079219420517300595
- BaeJPDobeshPPKlepserDGAdherence and dosing frequency of common medications for cardiovascular patientsAm J Manag Care201218313914622435907
- ClaxtonAJCramerJPierceCA systematic review of the associations between dose regimens and medication complianceClin Ther20012381296131011558866
- RichterAAntonSEKochPDennettSLThe impact of reducing dose frequency on health outcomesClin Ther20032582307233514512137
- SainiSDSchoenfeldPKaulbackKDubinskyMCEffect of medication dosing frequency on adherence in chronic diseasesAm J Manag Care2009156e22e3319514806
- BridgesJFPKinterETKidaneLHeinzenRRMcCormickCThings are looking up since we started listening to patients: trends in the application of conjoint analysis in health 1982–2007Patient20081427328222272995
- MarshallDBridgesJFPHauberABConjoint analysis applications in health – how are studies being designed and reported? An update on current practice in the published literature between 2005 and 2008Patient20103424925622273432
- de Bekker-GrobEWRyanMGerardKDiscrete choice experiments in health economics: a review of the literatureHealth Econ201221214517222223558
- HensherDARoseJMGreeneWHApplied Choice AnalysisCambridge (UK)Cambridge University Press2005
- HauberABGonzalezJMSchenkelBLoflandJMartinSThe value to patients of reducing lesion severity in plaque psoriasisJ Dermatolog Treat201122526627521781015
- JohnsonFRMohamedAFOzdemirSMarshallDAPhillipsKAHow does cost matter in health-care discrete-choice experiments?Health Econ201120332333020217834
- JohnsonFRBanzhafMRDesvousgesWHWillingness to pay for improved respiratory and cardiovascular health: a multiple-format stated-preference approachHealth Econ20009429531710862074
- HauberABGonzálezJMCoombsJSirulnikAPalaciosDScherzerNPatient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)Patient Prefer Adherence2011530731421792302
- HauberABMohamedAFBeamCMedjedovicJMauskopfJPatient preferences and assessment of likely adherence for hepatitis C virus treatmentsJ Viral Hepat201118961962720579276
- HauberABMohamedAFJohnsonFRFalveyHTreatment preferences and medication adherence of people with type 2 diabetes using oral glucose-lowering agentsDiabet Med200926441642419388973
- JohnsonFROzdemirSManjunathRHauberABBurchSPThompsonTRFactors that affect adherence to bipolar disorder treatments: a stated-preference approachMed Care200745654555217515782
- DeyAOrthogonal Fractional Factorial DesignsNew YorkHalstead Press1985
- HuberJZwerinaKThe importance of utility balance in efficient choice designsJ Marketing Res199633307317
- KanninenBJOptimal design for multinomial choice experimentsJ Market Res2002392214227
- KuhfeldWMarketing Research Methods in SAS: Experimental Design, Choice, Conjoint, and Graphical TechniquesCary (NC)SAS Institute Inc2010
- KuhfeldWTobiasFGarrattMEfficient experimental design with marketing research applicationsJ Mark Res1994314545557
- ZwerinaKHuberJKuhfeldWA General Method for Constructing Efficient Choice DesignsDurham (NC)Fuqua School of Business, Duke University1996
- GreeneWHEconometric Analysis5th edUpper Saddle River (NJ)Prentice Hall2003
- HeckmanJThe common structure of statistical models of truncation, sample selection, and limited dependent variables and a simple estimator for such modelsAnn Econ Soc Meas197654475492
- HeckmanJSample selection bias as a specification errorEconometrica1979471153161
- JendleJTorffvitORidderstråleMEricssonÅNilsenBBøgelundMWillingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme resultsJ Med Econ201215Suppl 21522853443
- PorzsoltFClouthJDeutschmannMHipplerHJPreferences of diabetes patients and physicians: a feasibility study to identify the key indicators for appraisal of health care valuesHealth Qual Life Outcomes2010812521050469
- ZhangXBullardKMGreggEWAccess to health care and control of ABCs of diabetesDiabetes Care20123571566157122522664